Table II.
Variable | No. | Darusentan | No. | Placebo |
---|---|---|---|---|
Baseline | ||||
Mean daytime SBP, mm Hg | 76 | 139.3±1.6 | 39 | 141.3±2.2 |
Mean nighttime SBP, mm Hg | 75 | 127.6±1.6 | 39 | 131.9±3.2 |
Mean daytime‐nighttime SBP ratio | 75 | 7.8±0.9 | 39 | 6.9±1.2 |
Week 10 (300‐mg dose) | ||||
Mean daytime SBP, mm Hg | 64 | 129.5±1.6 | 33 | 139.3±2.3 |
Mean nighttime SBP, mm Hg | 63 | 117.1±1.8 | 31 | 129.6±2.7 |
Mean daytime‐nighttime SBP ratio | 63 | 9.5±1.0a | 31 | 6.7±1.1 |
Mean change from baseline to week 10 | ||||
Daytime SBP, mm Hg | 64 | −10.6±1.4b | 33 | −2.2±2.3 |
Nighttime SBP, mm Hg | 62 | −11.9±1.6b | 31 | −3.3±2.6 |
Data are means ± SE. Mean daytime systolic blood pressure (SBP) was defined as the average ambulatory SBP level between 6 pm and 10 pm. Mean nighttime SBP was defined as the average ambulatory SBP level between 10 pm and 6 am. Daytime‐nighttime SBP ratio was calculated as the difference between mean daytime SBP level and mean nighttime SBP level divided by mean daytime SBP level and was expressed as a percentage. a P=.057 unadjusted for multiple comparisons. b P<.001 unadjusted for multiple comparisons. |